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A deficiency in pejvakin, a protein of unknown func-
tion, causes a strikingly heterogeneous form of hu-
man deafness. Pejvakin-deficient (Pjvk/) mice
also exhibit variable auditory phenotypes. Correla-
tion between their hearing thresholds and the num-
ber of pups per cage suggest a possible harmful
effect of pup vocalizations. Direct sound or electrical
stimulation show that the cochlear sensory hair cells
and auditory pathway neurons of Pjvk/ mice and
patients are exceptionally vulnerable to sound. Sub-
cellular analysis revealed that pejvakin is associated
with peroxisomes and required for their oxidative-
stress-induced proliferation. Pjvk/ cochleas dis-
play features of marked oxidative stress and im-
paired antioxidant defenses, and peroxisomes in
Pjvk/ hair cells show structural abnormalities
after the onset of hearing. Noise exposure rapidly
upregulates Pjvk cochlear transcription in wild-
type mice and triggers peroxisome proliferation in
hair cells and primary auditory neurons. Our results
reveal that the antioxidant activity of peroxisomes
protects the auditory system against noise-induced
damage.894 Cell 163, 894–906, November 5, 2015 ª2015 Elsevier Inc.INTRODUCTION
Mutations of PJVK, which encodes pejvakin, a protein of un-
known function present only in vertebrates, cause the DFNB59-
recessive form of sensorineural hearing impairment. In the first
patients described (Delmaghani et al., 2006), the impairment
was restricted to neurons of the auditory pathway, with auditory
brainstem responses (ABRs) displaying abnormally decreased
wave amplitudes and increased inter-wave latencies (Starr and
Rance, 2015). ABRs monitor the electrical response of auditory
pathways to brief sound stimuli, from the primary auditory neu-
rons synapsing with the sensory cells of the cochlea, the inner
hair cells (IHCs), to the colliculus in the midbrain (Møller and Jan-
netta, 1983). However, some DFNB59 patients were found to
have a cochlear dysfunction, as shown by an absence of the
otoacoustic emissions (OAEs) that are produced by the outer
hair cells (OHCs), frequency-tuned cells endowed with electro-
motility that mechanically amplify the sound stimulation of neigh-
boring IHCs (Ashmore, 2008). These patients had truncating
mutations of PJVK, whereas the previously identified patients,
with extant OAEs, had missense mutations (p.T54I or p.R183W)
(Ebermann et al., 2007; Schwander et al., 2007; Borck et al.,
2012). However, the identification of patients also carrying the
p.R183W missense mutation but lacking OAEs (Collin et al.,
2007) refuted any straightforward connection between the nature
of the PJVKmutation and the hearing phenotype. The severity of
deafness in DFNB59 patients varies from moderate to profound
Figure 1. Hearing Loss Variability and Greater Sensitivity to Con-
trolled Sound Exposure in Pjvk/ Mice
(A) ABR thresholds at 10 kHz in P30 Pjvk+/+ (n = 26 mice) and Pjvk/ (n = 48
mice) littermates.
(B) DPOAE thresholds at 10 kHz in P30 Pjvk+/+ (n = 14mice) and Pjvk/ (n = 48
mice) littermates. In ears with noDPOAE, even at 75 dB SPL (the highest sound
intensity tested), DPOAE thresholds were arbitrarily set at 80 dB SPL.
(C) Relationship between the number of pups raised together (determining
sound levels in the immediate environment) and ABR thresholds at 10 kHz in
P21 Pjvk/ pups. Inset: a time-frequency analysis of a mouse pup’s vocali-
zation. Pup calls from P0 to P21 form harmonic series of about 5 kHz, with the
most energetic harmonic at about 10 kHz. In a 12-pup litter, call levels reach
105 ± 5 dB SPL at the entrance to the ear canals of the pups.
(D) ABR thresholds at 10 kHz in P30 Pjvk+/+ and Pjvk/mice before (dots) and
after (crosses) controlled sound exposure. ns, not significant; ***p < 0.001.
See also Figure S1.and may even be progressive in some patients, suggesting that
extrinsic factors may influence the hearing phenotype.
We investigated the role of pejvakin, with the aimof determining
the origin of the phenotypic variability of theDFNB59 formof deaf-
ness. Our study of Pjvk knockout mouse models and of patients
revealed an unprecedented hypervulnerability of auditory hair
cells and neurons to sound exposure, accounting for phenotypic
variability. We found that pejvakin is a peroxisome-associated
protein involved in the oxidative-stress-induced proliferation of
this organelle.Pejvakin-deficientmice revealed the key roleofper-
oxisomes in the redox homeostasis of the auditory system and in
the protection against noise-induced hearing loss.
RESULTS
Heterogeneity in the Hearing Sensitivity of Pjvk/ Mice
We generated pejvakin-null (Pjvk/) mice carrying a deletion of
Pjvk exon 2, resulting in a frameshift at codon position 71(p.Gly71fs*9) (Figure S1; see the Supplemental Experimental
Procedures). ABR thresholds recorded on postnatal day 30
(P30) Pjvk/mice (n = 48) ranged from 35 to 110 dB SPL (sound
pressure level) at 10 kHz but never exceeded 30 dB SPL in their
Pjvk+/+ littermates (n = 26) (Figure 1A). This broad range of hear-
ing sensitivity in Pjvk/ mice, from near-normal hearing to
almost complete deafness, extended across the whole fre-
quency spectrum. The thresholds of distortion-product OAEs
(DPOAEs) at 10 kHz (i.e., the minimum stimulus required for
DPOAEs production by OHCs) also fell within an abnormally
large range of values, from 30 to 75 dB SPL, in 28 Pjvk/
mice, indicating an OHC dysfunction, and DPOAEs were unde-
tectable in another 20 Pjvk/ mice, suggesting a complete
OHC defect (Figure 1B). The absence of pejvakin in mice thus re-
sults in a puzzlingly large degree of hearing phenotype variability.
Hypervulnerability to the Natural Acoustic Environment
in Pjvk/ Mice
We investigated the variability of Pjvk/ auditory phenotypes,
by first determining the ABR thresholds of Pjvk/ littermates
from different crosses. Large differences were observed be-
tween crosses, withmuch fewer differences between thePjvk/
littermates of individual crosses. Litters with larger numbers of
pups (6 to 12) had higher ABR thresholds, suggesting that the
natural acoustic environment, with the calls of larger numbers
of pups, might be deleterious in Pjvk/ mice. Pups are vocally
very active from birth to about P20. We manipulated the level
of exposure to pup calls by randomly splitting large litters of
Pjvk/ pups into groups of 2, 4, 6 and 10 pups per cage, with
foster mothers, before P10, i.e., several days before hearing
onset. The ABR thresholds at P21 were significantly correlated
with the number of pups raised together (p < 0.001, r2 = 0.51)
(Figure 1C).
We then evaluated the effect of a controlled sound stimulation
on hearing, by presenting 1,000 tone bursts at 10 kHz, 105 dB
SPL (2-ms plateau stimulations separated by 60-ms intervals
of silence), energetically equivalent to a 3-min stay in the natural
environment of a 12-pup litter, while monitoring the ABRs during
sound exposure. These conditions are referred to hereafter as
‘‘controlled sound exposure.’’ We probed the effect of sound
exposure by ABR tests, which, limited to 50 repetitions of tone
bursts, did not influence the hearing thresholds of Pjvk/
mice. In a sample of P30 Pjvk/ mice with initial ABR threshold
elevation (below 35 dBSPL), controlled sound exposure affected
ABR thresholds in the 12–20 kHz frequency interval (correspond-
ing to the cochlear zones in which hair-cell stimulation was
strongest), with an immediate increase of 21.7 ± 10.3 dB (n =
8; p < 0.001), not observed in Pjvk+/+ mice (2.2 ± 2.4 dB, n =
12; p = 0.3) (Figure 1D). Pjvk/ mice transferred to a silent
environment after exposure displayed a further increase of
33.7 ± 16.0 dB (n = 8) 2 days after exposure. The threshold shift
decreased to 23.7 ± 18.0 dB at 7 days, and disappeared entirely
by 14 days. When exposed mice were returned to the box with
their littermates, their ABR continued to increase, at a rate of
15 dB per week. Pejvakin deficiency thus results in particularly
high levels of vulnerability to low levels of acoustic energy, and
the increase in ABR thresholds is reversible but only slowly
and in a quiet environment.Cell 163, 894–906, November 5, 2015 ª2015 Elsevier Inc. 895
Hair Cells and Auditory Pathway Neurons Are Affected
by Pejvakin Deficiency
To identify the cellular targets of the pejvakin deficiency, we spe-
cifically probed the function of auditory hair cells and neurons in
Pjvk/, hair cell-conditional Pjvk knockout (Pjvkfl/flMyo15-
cre+/), and Pjvk+/+ mice, at the age of 3 weeks, before and after
controlled sound exposure or controlled electrical stimulation.
The responses of the IHCs to sound-induced vibrations ampli-
fied by OHCs trigger action potentials in the distal part of primary
auditory neurons, at the origin of ABR wave I. In Pjvkfl/flMyo15-
cre+/ mice, which lack pejvakin only in the hair cells, ABR
wave I amplitude and latency at 105 dB SPL specifically probed
IHC function, because IHC responses to such loud sounds
are independent of OHC activity (Robles and Ruggero, 2001).
The larger wave I latency (1.58 ms in Pjvkfl/flMyo15-cre+/ mice
[n = 20] versus 1.32 ms in Pjvk+/+ littermates [n = 30]; p <
0.001) and lower wave I amplitude (37% of the amplitude in
Pjvk+/+ littermates; p < 0.001) suggested a dysfunction of the
IHCs. Controlled sound exposure induced further decreases in
ABR wave I amplitude in Pjvk/ and Pjvkfl/flMyo15-cre+/ mice
(48% and 55% of pre-exposure amplitude, respectively) with
respect to Pjvk+/+ mice (108%; p < 0.001 for both comparisons)
(Figure 2A), demonstrating thatPjvk/ IHCs are hypervulnerable
to sound. As shown above, OHCs are also affected by the pejva-
kin deficiency. Controlled sound exposure triggered a mean
decrease in the DPOAE amplitude of 16.9 ± 7.2 dB in the 12 to
20 kHz frequency interval in Pjvk/ mice with persistent
DPOAEs (n = 8; p < 0.0001), and an increase in DPOAE threshold,
but it had no effect on the DPOAEs of Pjvk+/+ mice (n = 9; p =
0.51) (Figure 2B). OHCs lacking pejvakin are thus also hypervul-
nerable to sound.
We investigated the effect of the absence of pejvakin on the
auditory pathway by comparing electrically evoked brainstem
responses (EEBR) in Pjvk/ and Pjvkfl/flMyo15-cre+/ mice
(see the Supplemental Experimental Procedures). The ampli-
tudes of the most distinctive EEBR waves, E II and E IV,
did not differ between the two types of mice (for wave E IV:
2.6 ± 1.8 mV in Pjvk/ mice [n = 18] and 2.2 ± 1.2 mV in
Pjvkfl/flMyo15-cre+/ mice [n = 11]; t test, p = 0.13). However,
following controlled electrical exposure at 200 impulses/s for
1 min, as opposed to electric-impulse stimulation with 16 im-
pulses/s for 10 s for pre- and post-exposure EEBR tests, E II
and E IV EEBR wave amplitudes got 41% and 47% smaller,
respectively, for at least 3 min, in Pjvk/ mice (n = 5; paired
t test, p = 0.02 and p = 0.01, respectively), but were unaffected
in Pjvkfl/flMyo15-cre+/ mice (n = 10; p = 0.83) (Figures 2D and
2G–2I). The E II-E IV interwave interval was 0.41 ms longer in
Pjvk/ mice (n = 5) than in Pjvkfl/flMyo15-cre+/ mice (n = 10;
p = 0.003), and controlled electrical exposure extended this in-
terval by a further 0.15 ms in Pjvk/ mice only (paired t test,
p = 0.001) (Figures 2H and 2I). Likewise, the latency interval be-
tween ABR wave I and wave IV (the counterpart of wave E IV),
abnormal in one-third of the Pjvk/ mice tested (with an ABR
threshold < 95 dB SPL, n = 12) (Figures 2C and 2E), got abnormal
in all of them after controlled sound exposure (0.16 ms further in-
crease; paired t test, p < 0.001). By contrast, it remained normal
in Pjvkfl/flMyo15-cre+/ mice (n = 10 ears; p = 0.73) (Figures 2C
and 2F). Thus, the absence of pejvakin affects the propagation896 Cell 163, 894–906, November 5, 2015 ª2015 Elsevier Inc.of action potentials in the auditory pathway after both controlled
electrical and sound exposure in the Pjvk/ mice.
To clarify whether these abnormalities were of neuronal or glial
origin, we performed a rescue experiment in Pjvk/ mice, using
adeno-associated virus 8 (AAV8) vector-mediated transfer of the
murine pejvakin cDNA (AAV8-Pjvk). AAV8 injected into the
cochlea transduces the primary auditory neurons (cochlear gan-
glion neurons) and neurons of the cochlear nucleus (Figure S2A),
but not the hair cells. All Pjvk/ mice (n = 7) injected on P3 and
tested on P21 had normal ABR interwave I-IV latencies (Fig-
ure 2J), and their EEBR wave-E IV amplitude was insensitive to
controlled electrical stimulation (1.91 ± 0.97 mV before and
1.87 mV ± 1.07 after stimulation; paired t test, p = 0.59) (Figures
2K and 2L). The absence of pejvakin thus renders auditory
pathway neurons hypervulnerable to exposure to mild, short
sound stimuli.
Hypervulnerability to Sound in DFNB59 Patients
We then investigated whether the hearing of DFNB59 patients
was also hypervulnerable to sound exposure. We tested five
patients carrying the p.T54I mutation (Delmaghani et al., 2006).
Transient-evoked OAEs (TEOAEs) assessing OHC function
over a broad range of frequencies were detected for all ears,
despite the severe hearing impairment (hearing threshold in-
creasing from 66 dB HL at 250 Hz to 84 dB at 8 kHz). Following
minimal exposure to impulse stimuli (clicks at 99 dB nHL), ABR
waves were clearly identified in response to 250 clicks. When
exposure was prolonged to 1,000 clicks (the standard proce-
dure), wave V, the equivalent of mouse ABR-wave IV, which
was initially conspicuous, displayed a decrease in amplitude
(to 39% ± 30% of its initial amplitude) and an increase in latency
(of 0.30 ± 0.15 ms) (Figures 3A, 3C, and 3D). In parallel, the
I-V interwave interval increased by 0.30 ± 0.15 ms. Wave-V
amplitude and latency recovered fully after 10 min of silence
(Figure 3B). In control patients with sensorineural hearing im-
pairment of cochlear origin matched for ABR thresholds,
similar sound stimulation did not affect ABR wave-V amplitude
(105% ± 14% of the initial amplitude after exposure; n = 13 pa-
tients) or latency (0.02 ± 0.07 ms change after exposure) (Fig-
ures 3C and 3D). Exposure of the DFNB59 patients to 1,000
clicks also affected TEOAEs (6.1 ± 5.2 dB nHL decrease in ampli-
tude; paired t test, p = 0.02). Therefore, as in pejvakin-deficient
mice, the cochlear and neuronal responses of DFNB59 patients
were affected by exposure to low-energy sound.
Redox Status Abnormalities and ROS-Induced Cell
Damage in the Cochlea of Pjvk/ Mice
We studied the Pjvk/ cochlea by light microscopy on semithin
sections and electron microscopy. On P15 and P21, both OHCs
and IHCs were normal in number and shape. Their hair bundles
(the mechanoreceptive structures responding to sound), the rib-
bon synapses of the IHCs, and their primary auditory neurons
were unmodified (data not shown). On P30, we observed the
loss of a few OHCs (16% ± 11%, n = 5 mice), restricted to the
basal region of the cochlea (tuned to high-frequency sounds).
From P30 onward, OHCs, cochlear ganglion neurons, and then
IHCs disappeared, and the sensory epithelium (organ of Corti)
progressively degenerated (Figure S3A).
Figure 2. Effects on Auditory Function of Brief Exposure to Moderately Intense Stimuli in Pjvk+/+, Pjvk/, and Pjvkfl/flMyo15-cre+/ Mice
(A–C) ABR wave I amplitude (A), DPOAE amplitude (B), and ABR interwave I-IV latency (C) in Pjvk+/+, Pjvk/, and Pjvkfl/flMyo15-cre+/ mice, before (dots) and
after (crosses) controlled sound exposure, revealing the hypervulnerability to sound of both types of cochlear hair cells (IHCs and OHCs) and of the neural
pathway.
(D) EEBR wave E IV amplitude before and after controlled electrical exposure in Pjvk/ and Pjvkfl/flMyo15-cre+/ mice was abnormal and hypervulnerable only
when pejvakin is absent from auditory neurons (Pjvk/ mice).
(E and F) Examples of ABRs in Pjvk/ and Pjvkfl/flMyo15-cre+/ mice: the latency of wave I is affected by controlled sound exposure in both mutant mice, and
wave IV displays an additional increase in latency only in Pjvk/ mice.
(G–I) Examples of EEBRs in Pjvk+/+ (G), Pjvk/ (H), and Pjvkfl/flMyo15-cre+/ (I) mice; EEBRs are affected by controlled electrical exposure only in Pjvk/ mice.
(legend continued on next page)
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We investigated possible changes in gene expression in the
organ of Corti of P15 Pjvk/ mice, by microarrays (see the
Supplemental Experimental Procedures). Eighteen genes had
expression levels at least 1.5-fold higher or lower in Pjvk/
mice than in Pjvk+/+ mice. Marked differences were observed
for four genes involved in the redox balance—CypA, Gpx2, c-
Dct, and Mpv17—encoding cyclophilin A, glutathione peroxi-
dase 2, c-dopachrome tautomerase, and Mpv17, respectively
(Table S1). All of these genes were downregulated in Pjvk/
mice, a result confirmed by qRT-PCR (Figure S4A), and all
encode antioxidant proteins, suggesting that Pjvk/ mice
have impaired antioxidant defenses (Table S1).
We thus assessed the level of oxidative stress in the cochlea of
P21Pjvk/mice, by determining the ratio of reduced to oxidized
glutathione (GSH:GSSG). The GSSG content was about three
times larger than in Pjvk+/+ mice, whereas the GSH content
was 23% smaller, resulting in a GSH:GSSG ratio in Pjvk/ co-
chleas reduced by a factor of 3.4 (Figure 4A). Pejvakin deficiency
thus results in cochlear oxidative stress.
We assessed lipid peroxidation by reactive oxygen species
(ROS) in Pjvk/ mice, by immunofluorescence-based detection
of the by-product 4-hydroxy-2-nonenal (4-HNE). Strong immu-
noreactivity was observed in P60 Pjvk/ hair cells and cochlear
ganglion neurons (Figure S3B). Quantification of lipid peroxida-
tion in microdissected organs of Corti from P30 Pjvk/ and
Pjvk+/+ mice, showed a moderate, but statistically significant,
increase of the malondialdehyde content in the absence of
pejvakin (2.15 ± 0.14 mM in Pjvk/ versus 1.84 ± 0.11 mM in
Pjvk+/+ mice; p = 0.04). Thus, pejvakin deficiency led to impaired
antioxidant defenses in the cochlea, resulting in ROS-induced
cell damage.
We then studied electrophysiological features of IHCs and
OHCs in the mature cochlea of P19–P21 Pjvk/ mice. In IHCs,
the number of synaptic ribbons, Ca2+ currents, and synaptic
exocytosis were unaffected (Figure S5A). We investigated
whether Pjvk/ mice display the main K+ currents found in
mature IHCs, specifically IK,f, which plays a major part in IHC
repolarization and is involved in the high temporal precision of
action potentials in postsynaptic nerve fibers, IK,s, and IK,n (Oliver
et al., 2006). The IK,f current that flows through the large conduc-
tance voltage- and Ca2+-activated potassium (BK) channels, a
well-known target of ROS (Tang et al., 2004), was detected in
only 4 out of 11 Pjvk/ IHCs, and the mean number of spots im-
munolabeled for the BK a-subunit per IHC was much lower in
Pjvk/ mice (5.0 ± 1.4, n = 283 IHCs from seven mice) than in
Pjvk+/+ mice (13.9 ± 2.6, n = 204 IHCs from nine mice; t test,
p < 0.001). By contrast, the IK,s and IK,n currents were not
affected (Figures 4B and S5B). The electromotility of OHCs
was moderately impaired in Pjvk/mice (Figure S5C). This con-
trasted with the total loss of DPOAE in a large majority of Pjvk/
mice from P15 on, even at the highest possible stimulus level of
75 dB SPL. It thus pinpointed the existence of an additional
defect, likely a mechanoelectrical transduction defect, the(J–L) Neuronal function rescue in Pjvk/ mice by transduction with AAV8-Pjvk: e
hypervulnerability to electrical stimulation (K), and on EEBR interwave E II-E IV
indicate the positions of waves I and IV on ABR traces and of waves E II and E IV
See also Figures S1 and S2A.
898 Cell 163, 894–906, November 5, 2015 ª2015 Elsevier Inc.main determinant of DPOAEs at high stimulus levels (Avan
et al., 2013). The decrease of the cochlear microphonic potential
that reflects mechanoelectrical transduction currents through
OHCs of the basal-most cochlear region, indeed corroborated
the DPOAE measurements: this potential, recorded for a 5-kHz
sound stimulus at 95 dB SPL, was always larger than 10 mV in
Pjvk+/+ mice (n = 8), but fell between 5 and 3 mV in the P21Pjvk/
mice with residual DPOAEs (n = 2), and below 1 mV, in the Pjvk/
mice without persisting DPOAEs (n = 6). Taken together, oxida-
tive stress in the Pjvk/ cochlea impacts various electrophysio-
logical properties of the hair cells, particularly mechanoelectrical
transduction and K+ current through BK channels.
Mitochondrial defects are a common cause of ROS overpro-
duction. However, we did not find evidence that mitochondria
were damaged, as vulnerability of the mitochondrial membrane
potential,Dcm, to the uncoupler carbonyl cyanide 4-(trifluorome-
thoxy)phenylhydrazone (FCCP) in the organ of Corti and
cochlear ganglion was similar in P17-P30 Pjvk/ and Pjvk+/+
mice, and analysis of Pjvk/ hair cells by transmission electron
microscopy (TEM) revealed no mitochondrial abnormalities (Fig-
ure S5D; data not shown).
Pejvakin Is a Peroxisome-Associated Protein
By using Pjvk/ cochlea as control, we found that neither the
commercially available antibodies nor our initial polyclonal anti-
body (Delmaghani et al., 2006) specifically recognized pejvakin
(data not shown). Given the limited divergence of the pejvakin
amino-acid sequence among vertebrates, we tried to elicit an
immune response in Pjvk/ mice (see the Experimental Proce-
dures). The monoclonal antibody obtained, Pjvk-G21, labeled
peroxisomes stained by peroxisome membrane protein 70
(PMP70) antibodies in transfected HeLa cells expressing pejvakin
(Figure S6A) and in the human HepG2 hepatoblastoma cell line,
which is particularly rich in this organelle (Figure 5A). The speci-
ficity of the Pjvk-G21 antibodywas demonstrated by the immuno-
labeling of peroxisomes in the hair cells of Pjvk+/+, but not of
Pjvk/ and Pjvkfl/flMyo15-cre+/ mice (Figures 5B and S6B).
Prediction programs failed to detect the PTS1 or PTS2 motifs
in the pejvakin sequence (Mizuno et al., 2008), the targeting sig-
nals for the importation of peroxisomal matrix proteins into the
organelle (Smith and Aitchison, 2013), suggesting that pejvakin
is a peroxisomal membrane or membrane-associated protein.
Structural Abnormalities of Peroxisomes in the Hair
Cells of Pjvk/ Mice
We investigated the distribution andmorphology of peroxisomes
by TEM. Peroxisomes were identified on the basis of catalase
activity detection using 3,30-diaminobenzidine as substrate.
We focused on OHCs, the first to display a dysfunction in Pjvk/
mice. On P30, but not on P15, both the distribution and shape of
peroxisomes differed between Pjvk/ and Pjvk+/+ mice (Fig-
ure 5E). In Pjvk+/+ OHCs, the peroxisomes were restricted to
an area immediately below the cuticular plate. In Pjvk/ mice,ffects on ABR interwave I-IV latency (J), on EEBR wave E IV amplitude and its
latency (one example is shown in L, to be compared with H). Vertical arrows
on EEBR traces. ns, not significant; ***p < 0.001. Error bars represent the SD.
Figure 3. Hypervulnerability to Sound in DFNB59 Patients
(A) ABR waves I, III, and V (vertical arrows) in one ear of a patient carrying the
PJVK p.T54I mutation, in response to 250, 500, and 1000 impulse stimuli
(clicks) at 99 dB nHL.
(B) Repeated ABRs after 10 min of silence, with an even larger vulnerability of
waves I, III, and V.
(C andD) Distributions of the amplitude (C) and latency (D) of ABRwave V in the
tested sample of p.T54I patients (n = 8 ears), and in a control group of patientsthe peroxisomes located just below the cuticular plate were
slightly larger than those inPjvk+/+mice. Strikingly, irregular cata-
lase-containing structures, some of which were juxtaposed,
were present in the perinuclear region, in the immediate vicinity
of the nuclear membrane of all Pjvk/ OHCs, but not of
Pjvk+/+ OHCs (Figure 5E). The lack of pejvakin thus results in
peroxisome abnormalities in OHCs after the onset of hearing.
Pejvakin Is Involved in Oxidative Stress-Induced
Peroxisome Proliferation
In HepG2 cells, protrusions emerging from some peroxisomes,
the first step of peroxisome biogenesis from pre-existing perox-
isomes, were immunoreactive for pejvakin. String-of-beads
structures corresponding to elongated and constricted peroxi-
somes, preceding final fission (Smith and Aitchison, 2013),
were also pejvakin-immunoreactive, suggesting a role for this
protein in peroxisome proliferation (Figure S6C). Peroxisomes
actively contribute to cellular redox balance, by producing and
scavenging/degrading H2O2 through a broad spectrum of oxi-
dases and peroxidases (especially catalase), respectively
(Schrader and Fahimi, 2006). Because Pjvk/ mice displayed
features of marked oxidative stress in the cochlea, we investi-
gated the possible role of pejvakin in peroxisome proliferation
in response to oxidative stress induced by H2O2 (Lopez-Huertas
et al., 2000). Embryonic fibroblasts derived from Pjvk+/+ and
Pjvk/ mice were exposed to H2O2 (see the Supplemental
Experimental Procedures). In unexposed cells, the number of
peroxisomes was similar between the two genotypes (t test,
p = 0.82). After H2O2 treatment, it increased by 46% in Pjvk
+/+ fi-
broblasts (p = 0.004), but remained unchanged in Pjvk/ fibro-
blasts (p = 0.83), resulting in a statistically significant difference
between the two genotypes (p < 0.001) (Figures 5C and S7A).
We then asked whether mutations reported in DFNB59 pa-
tients also affect peroxisome proliferation. We assessed the
number of peroxisomes in transfected HeLa cells producing
EGFP alone, EGFP and murine pejvakin, or EGFP and one of
the mutated forms of murine pejvakin carrying the mutations
responsible for DFNB59 (p.T54I, p.R183W, p.C343S, or
p.V330Lfs*7). Cells producing the non-mutated pejvakin had
larger numbers of peroxisomes than cells producing EGFP
alone, whereas cells producing any of the mutated forms of pej-
vakin (mutPjvk-IRES-EGFP) had smaller peroxisome numbers.
In addition, many of these cells contained enlarged peroxi-
somes, a feature typical of peroxisome proliferation disorders
(Ebberink et al., 2012) (Figure 5D and S7B). Together, these re-
sults strongly suggest that pejvakin is directly involved in the pro-
duction of new peroxisomes from pre-existing peroxisomes.
Upregulation of Pjvk Cochlear Transcription and
Peroxisome Proliferation in Response to Sound
We then asked whether pejvakin is involved in the physiological
response to sound. We first assessed the transcription of Pjvk(n = 13) with cochlear hearing impairment and matched ABR thresholds,
before and after exposure to clicks #250 to #1000. Boxes extend from the 25th
to the 75th percentile. Horizontal bars and vertical bars indicate median values
and extremes, respectively. Unlike the unaffected controls, all p.T54I patients
displayed markedly decreased amplitudes and increased latencies.
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Figure 4. Increased Oxidative Stress and
ROS-Induced Cell Damage in the Pjvk/
Cochlea
(A) Reduced glutathione (GSH) (left bar chart),
oxidized-glutathione (GSSG) (middle bar chart)
contents, and GSH:GSSG ratio (right bar chart) in
P21 Pjvk/ versus Pjvk+/+ cochlea. Error bars
represent the SEM of three independent experi-
ments. See also Figure S3.
(B) Marked decrease in the BK a-subunit im-
munolabeling in Pjvk/ IHCs. Left: P20 Pjvk+/+ and
Pjvk/ IHCs. Scale bar is 5 mm. Right: quantitative
analysis of BK channel clusters. Error bars repre-
sent the SD. See also Figure S5B. *p < 0.05, ***p <
0.001.
See also Figures S3 and S5.and of CypA, Gpx2, c-Dct, and Mpv17, which were downregu-
lated in Pjvk/ mice, in microdissected organs of Corti from
P21 wild-type mice, with or without prior sound stimulation (5–
20 kHz, 105 dB SPL for 1 hr; see the Supplemental Experimental
Procedures). Transcript levels were analyzed by qRT-PCR at
various times (1, 3, 6, and 18 hr) after sound exposure (Figure 6A).
Pjvk transcript levels had increased by factors of 1.9 ± 0.1 and
3.5 ± 0.7, mean ± SEM, after 1 and 6 hr, respectively. CypA, c-
Dct, and Mpv17 were also upregulated after 6 hr (by factors of
6.6 ± 1.2, 4.3 ± 0.6, and 1.5 ± 0.1, respectively), as were c-Fos
andHsp70, used as a positive control, but notGpx2. Thus, noise
exposure leads to an upregulation of the transcription of Pjvk and
of genes downregulated inPjvk/mice, and this effect is depen-
dent on acoustic energy level of the stimulation (Figure S4B).
This result predicted that sound exposure would lead to
peroxisome proliferation in the auditory system of wild-type
mice. 6 hr after exposure (5–20 kHz, 105 dB SPL for 1 hr),
the numbers of peroxisomes were unchanged (34.5 ± 0.8 and
35.9 ± 1.0, mean ± SEM, per IHC from unexposed and sound-
exposed mice, respectively, n = 75 cells from six mice; t test,
p = 0.25). However, at 48 hr, they had markedly increased, by
a factor of 2.3, in both IHCs and OHCs (84.7 ± 5.0 per IHC and
16.5 ± 1.0 per OHC, n = 90 cells and n = 150 cells from six
mice, respectively) compared to unexposed mice (36.8 ± 3.0
per IHC and 7.3 ± 0.4 per OHC, n = 90 cells and n = 150 cells
from six mice, respectively; t test, p < 0.0001 for both compari-
sons). The number of peroxisomes had also increased, by
35%, in the dendrites of primary auditory neurons (1.7 ± 0.1
and 2.3 ± 0.2 peroxisomes per micrometer of neurite length,
n = 40 neurites from five unexposed and five sound-exposed
Pjvk+/+ mice, respectively; t test, p = 0.003) (Figure 6B).
Therapeutic Approaches in Pjvk/ Mice
Based on these results, we tested whether the classical antiox-
idant drug N-acetyl cysteine (NAC) (either alone or associated
with a-lipoic acid and a-tocopherol; see the Supplemental900 Cell 163, 894–906, November 5, 2015 ª2015 Elsevier Inc.Experimental Procedures) administered
to Pjvk/ pups could improve their hear-
ing. The ABR thresholds of P21 NAC-
treated Pjvk/ pups (n = 21) were about
10 dB lower than those of untreatedPjvk/ pups (n = 24) for all frequencies tested (t test, p <
0.001 for all comparisons) (Figure 7A). The amplitude of the
ABR wave I elicited at 105 dB SPL (4.35 ± 1.16 mV, n = 21) was
the same as that of Pjvk+/+ mice (4.36 ± 1.15 mV, n = 18; t test,
p = 0.97) and greater than that of untreated Pjvk/ mice (1.88
± 1.07 mV, n = 24; t test, p < 0.001) (Figure 7B). EEBRs were
more resistant to the high-rate electrical stimulation in treated
than in untreated mutant mice (Figure 7C). Conversely, NAC
had no beneficial effect on OHCs (data not shown). The associ-
ation of NAC with a-lipoic acid and a-tocopherol did not perform
any better (data not shown).
Full recovery of the neuronal phenotype was achieved by the
intracochlear injection of AAV8-Pjvk (see above). As hair cells
are not transduced by AAV8, we investigated whether AAV2/8,
which transduces hair cells only (Figure S2B), could rescue
the Pjvk/ hair-cell phenotype. The auditory function of Pjvk/
mice (n = 7, four pups per cage in every experiment) receiving
intracochlear injections of AAV2/8-Pjvk-IRES-EGFP on P3 was
assessed on P21, and the percentage of transduced IHCs
and OHCs was evaluated in each injected and contralateral
(not injected) cochlea, on the basis of EGFP fluorescence.
Improvements in ABR thresholds of 20 to 30 dBSPLwith respect
to untreated mice were observed for frequencies between 10
and 20 kHz (t test, p < 0.001 for all comparisons; Figure 7D).
Upon injection of AAV2/8-EGFP, DPOAEs, ABR thresholds,
and ABR wave I amplitude and latency were similar to those of
untreated Pjvk/ mice (data not shown). A partial reversion of
the OHC dysfunction was obtained, with detectable DPOAEs
in pejvakin cDNA-treated cochleas (threshold 54.0 ± 10.7 dB),
but not in contralateral, untreated cochleas (Figure 7E). DPOAE
thresholds were linearly correlated (r2 = 0.74, p < 0.001) with
the number of EGFP-tagged OHCs (Figure 7F), suggesting
that the normalization of DPOAE thresholds may be possible if
all OHCs could be transduced. The latency of the ABR wave I
in response to a 105 dB SPL stimulation decreased significantly
(1.38 ± 0.11 ms for the treated ears; n = 6, versus 1.53 ± 0.10 ms
Figure 5. Pejvakin Is a Peroxisome-Associated Protein Involved in the Oxidative Stress-Induced Peroxisomal Proliferation
(A and B) Immunolabeling of PMP70 and endogenous pejvakin in a HepG2 cell (A) and in two P20 Pjvk+/+ IHCs (B). See also Figure S6B.
(C) Number of peroxisomes in Pjvk+/+ and Pjvk/ mouse embryonic fibroblasts (MEFs) subjected to 0.5 mM H2O2 versus untreated MEFs (n = 30 cells for each
condition). See also Figure S7A.
(D) Untransfected HeLa cells (NT) and transfected cells producing either EGFP alone or EGFP, together with the wild-type pejvakin (Pjvk) or a mutated Pjvk
(p.T54I, p.R183W, p.C343S, or p.V330Lfs*7). Left panel: bar chart showing the numbers of peroxisome per cell 48 hr after transfection. There were on average
(legend continued on next page)
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Figure 6. Effect of Exposure to Loud Sounds
on the Cochlear Expression of Pjvk and the
Number of Peroxisomes in Cochlear Hair
Cells and Ganglion Neurons
(A) Pjvk, c-Dct, CypA,Mpv17, and Gpx2 transcript
levels assessed by qRT-PCR in P21 Pjvk+/+ organ
of Corti 1, 3, 6, and 18 hr after sound exposure
(5–20 kHz, 105 dB SPL for 1 hr). The levels of c-Fos
and Hsp70 transcripts were used as positive con-
trols. See also Figure S4B.
(B) Peroxisome proliferation in P21 Pjvk+/+ hair
cells and cochlear ganglion neurons after sound
exposure (same conditions as in A). Peroxisomes
were counted 48 hr after sound exposure. OHCs,
IHCs, and neuronal processes stained for F-actin,
myosin VI, and neurofilament protein NF200,
respectively. In OHCs and IHCs, the peroxisomes
are located below the CP and throughout the
cytoplasm, respectively. For OHCs, both a lateral
view and a transverse optical section at the level of
CP (scheme on the right) are shown. The number of
peroxisomes was increased in OHCs, IHCs, and
dendrites after sound exposure. N, cell nucleus.
***p < 0.001. Error bars represent the SEM. Scale
bars are 5 mm.
See also Figure S4 and Table S1.for the contralateral, untreated ears; paired t test, p = 0.03)
(Figure 7G), and its amplitude increased into the normal range
(7.34 ± 0.80 mV versus 2.93 ± 0.92 mV; paired t test, p < 0.001)
(Figure 7H), in relation to the number of EGFP-tagged IHCs
(r2 = 0.89 for wave I amplitude, p < 0.001; Figure 7I). No correc-
tion of the interwave I-IV latency was observed, as expected
(data not shown).
Finally, we investigated the effect of the transduction of
Pjvk/ IHCs by AAV2/8-Pjvk-IRES-EGFP on their peroxisomes.33% more peroxisomes in cells producing both EGFP and Pjvk (n = 200) than in cells producing EGFP alone
peroxisome size, x (0.6–0.8 mm, 0.8–1.0 mm, and >1.0 mm), in two perpendicular directions, the proportion of
Figure S7B.
(E) Abnormalities in shape and distribution of peroxisomes in mature Pjvk/ OHCs detected by TEM (P30
Insets [middle panel]: enlarged views of individual peroxisomes. In Pjvk+/+ OHCs, peroxisomes are grouped ju
none detected in the perinuclear region (n = 33 sections, upper bar chart). In Pjvk/OHCs, some peroxisome
containing structures, misshapen peroxisomes (arrows), are detected in the perinuclear region (n = 24 section
CP are larger in Pjvk/OHCs (n = 92 peroxisomes) than in Pjvk+/+ OHCs (n = 89 peroxisomes) (lower bar char
represent the SEM. Scale bars are 5 mm in (A) and (B) and 0.5 mm in (E).
See also Figures S6 and S7.
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of peroxisomes in IHCs of P21 Pjvk/
and AAV2/8-Pjvk-IRES-EGFP-injected
Pjvk/ mice did not differ from that of
Pjvk+/+ mice (30.5 ± 1.9, 32.3 ± 2.1, and
36.8 ± 3.0 peroxisomes, mean ± SEM
per IHC, n = 60 cells from four Pjvk/
and four AAV2/8-Pjvk Pjvk/ mice, and
n = 90 cells from six Pjvk+/+ mice, respec-
tively; t test, p = 0.11 and p = 0.30, respec-
tively). By contrast, 48 hr after sound
exposure (5–20 kHz) at 105 dB SPL for
1 hr, the number of peroxisomes haddecreased by 63% in Pjvk/ IHCs (30.5 ± 1.9 and 11.2 ± 1.3
peroxisomes per IHC, n = 75 cells from five unexposed and
five sound-exposed Pjvk/ mice, respectively; t test, p <
0.0001), and enlarged PMP70-labeled structures were pre-
sent close to the nucleus (Figure 7J). In response to the
same sound but of a lower intensity, i.e., 97 dB SPL for 1 hr,
the number of peroxisomes was unchanged in Pjvk/ IHCs
(30.5 ± 1.9 and 34.6 ± 2.3 peroxisomes per IHC, n = 60 cells
from four unexposed and four sound-exposed Pjvk/ mice,(n = 150). Right panel: for every range of enlarged
cells containing at least one peroxisome. See also
Pjvk/ [middle and right] and Pjvk+/+ [left] OHCs).
st under the cuticular plate (CP) (arrowheads), with
s remain under the CP (arrowheads), but catalase-
s, upper bar chart). Peroxisomes located under the
t). N, cell nucleus. **p < 0.01, ***p < 0.001. Error bars
Figure 7. Therapeutic Approaches in Pjvk/ Mice
(A–C) Effect of N-acetyl cysteine (NAC) on auditory function inPjvk/mice. (A) ABR thresholds in untreated versus NAC-treated P21Pjvk/mice. (B) ABRwave I
amplitude for 10 kHz tone bursts in Pjvk+/+ and untreated Pjvk/ versus NAC-treated Pjvk/ mice at P21. (C) EEBR wave E IV amplitude before (dots) and after
(crosses) controlled electrical stimulation of the cochlear nerve at 200 impulses/s for 1 min in Pjvk+/+, untreated Pjvk/, and NAC-treated Pjvk/ mice.
(D–I) Effect of AAV2/8-Pjvk-IRES-EGFP transferred into the cochlear hair cells on the auditory function ofPjvk/mice. See also Figure S2B. (D) ABR thresholds at
10, 15, and 20 kHz in AAV2/8-Pjvk-IRES-EGFP-treated versus untreated Pjvk/mice. (E and H) DPOAE threshold (E) and ABR wave I amplitude (H) at 10 kHz in
(legend continued on next page)
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respectively; t test, p = 0.17), and no enlarged PMP70-stained
structures were detected (data not shown). The absence of pej-
vakin thus resulted in defective sound-induced peroxisomal pro-
liferation (both at 105 dB SPL and 97 dB SPL) and, even, in
peroxisome degeneration (at 105 dB SPL) in IHCs. In Pjvk/
mice injected with AAV2/8-Pjvk-IRES-EGFP on P3 and exposed
to 105 dB SPL for 1 hr on P21, enlarged PMP70-labeled struc-
tures were no longer detected in transduced IHCs, and the num-
ber of peroxisomes increased by 35% (32.3 ± 2.1 and 43.7 ± 3.0
peroxisomes per IHC, n = 60 cells from unexposed and exposed
transduced Pjvk/ IHCs, respectively; t test, p = 0.002) (Fig-
ure 7J). We conclude that pejvakin re-expression fully protects
Pjvk/ IHCs from the degenerescence of peroxisomes and
partially restores their impaired adaptive proliferation.
DISCUSSION
Noise-induced hearing loss (NIHL) is the second most common
form of sensorineural hearing impairment after presbycusis in
the United States (Dobie, 2008). Here, we describe a genetic
form of NIHL, by showing that pejvakin deficiency in mice and
DFNB59 patients leads to hypervulnerability to sound, due to a
peroxisomal deficiency. To our knowledge, a peroxisomal cause
of an isolated (non-syndromic) form of inherited deafness has not
been reported yet. The peroxisome emerges as a key organelle in
the redox homeostasis of the auditory system, for coping with the
overproduction of ROS induced by high levels of acoustic energy.
Acoustic energy is the main determinant of NIHL. The LEX,8 hr
(for level of exposure over an 8-hr workshift) index has been
defined such that an LEX,8 hr of X dB delivers the same energy
as a stable sound of X dB played over a period of 8 hr. Chronic
occupational exposures to less than 85 dB (or 80 dB, depending
on the country) are deemed safe. In Pjvk/ mice, a single expo-
sure to 63 dB LEX,8 hr increased hearing thresholds by 30 dB, with
full recovery occurring after about 2 weeks. By contrast, a ten
times more energetic exposure to a LEX,8 hr of 73 dB in wild-
type mice of the same strain produces only an 18 dB shift in
threshold, with a recovery time of 12 hr (Housley et al., 2013).
This hypersensitivity of Pjvk/ mice to noise suggests that the
LEX,8 hr of about 83 dB for a cage of ten pups is sufficient to ac-
count for permanent hearing loss in these Pjvk/ pups, while
some of those housed in small numbers in quiet rooms can
display near-normal hearing thresholds (see Figure 1C). Likewise,
the auditory function of DFNB59 patients was transiently affected
by a 57 dB LEX,8 hr exposure, routinely used in ABR tests.
NIHL involves the excessive production of ROS, overwhelming
the antioxidant defense system and causing irreversible oxidative
damage to DNA, proteins, and lipids within the cell (Henderson
et al., 2006). Noise-induced oxidative stress results in the produc-
tion of H2O2 and other ROS as by-products, thought to derive
from the intense solicitation of mitochondrial activity, and severaltreated versus untreated contralateral ears. (G) ABR wave I latency in treated vers
the proportion of EGFP-tagged (i.e., transduced) OHCs. Six untreated ears have
Correlation between ABR wave I amplitude at 10 kHz, 105 dB SPL, and the perc
(J) Effect of AAV2/8-Pjvk-IRES-EGFP on the peroxisomes in Pjvk/ IHCs. Upper
mice 48 hr after sound exposure (5–20 kHz, 105 dB SPL for 1 hr) (peroxisome abno
the SEM in (J). ns, not significant; *p < 0.05, **p < 0.01, ***p < 0.001.
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lemiller et al., 1999; Brown et al., 2014). Our studies of pejvakin-
deficient mouse mutants and rescue experiments targeting the
hair cells and auditory neurons unambiguously show that IHCs,
OHCs, primary auditory neurons, and neurons of the cochlear nu-
cleus are hypervulnerable to sound in the absence of pejvakin,
which is consistent with previous results showing that hair cells
and neurons of the auditory system are targets of NIHL (Wang
et al., 2002; Kujawa and Liberman, 2009; Imig and Durham,
2005). However, our study goes one step further by implicating
a possible common mechanism: peroxisomal failure, the impor-
tance of which is demonstrated by the impairment of the redox
homeostasis caused by pejvakin deficiency. It also reveals a ma-
jor cause of the unusually high level of phenotypic variability
observed in pejvakin-deficient mice and humans: the difference
in sound exposure and the inability of the peroxisomes to cope
with the resultant activity-dependent oxidative stress in the
absence of pejvakin. Incidentally, this can account for the
apparent paradox that mice carrying the R183W mutation in pej-
vakin displayed a much more severe neural pathway defect than
the Pjvk/ mice (Delmaghani et al., 2006). Due to the preserva-
tion of hair cell functions, the auditory neurons of R183W mutant
mice should be strongly stimulated, whereas the early permanent
damage to cochlear hair cells in Pjvk/ mice acts as a protective
‘‘muffler’’ of the neuronal pathway.
In mammals, the number and metabolic functions of peroxi-
somes differ between cell types. However, all cell types are
able to adapt rapidly to modifications in physiological conditions
by changing the number, shape, size, and molecular content of
peroxisomes, resulting in considerable functional plasticity of
these organelles (Schrader et al., 2012; Smith and Aitchison,
2013). Our experiments on Pjvk/ and Pjvk+/+ mouse embryonic
fibroblasts stressed with H2O2 showed that pejvakin is critically
involved in the oxidative stress-induced proliferation of peroxi-
somes through growth and fission of pre-existing peroxisomes.
The molecular machinery underlying this adaptive process is still
poorly understood beyond the involvement of Pex11a (Li et al.,
2002). Of note, the absence of pejvakin only affects the prolifer-
ation of peroxisomes from pre-existing peroxisomes, but not the
constitutive biogenesis of this organelle. Accordingly, structural
abnormalities of peroxisomes in Pjvk/ mice became apparent
only after hearing onset, in the context of the oxidative stress
produced by noise exposure. By contrast, the PEX gene defects
causing Zellweger syndrome spectrum (ZSS) disorders (Water-
ham and Ebberink, 2012) and rhizomelic chondrodysplasia
punctata affect the constitutive biogenesis of peroxisomes.
Hearing impairment in ZSS disorders involves a severe impair-
ment of neuronal conduction and has been attributed to defects
in the synthesis of two essential myelin sheath components—
plasmalogens and docosahexaenoic acid—which is critically
dependent on peroxisomes. Our results suggest that ZSS alsous untreated contralateral ears. (F) Correlation between DPOAE thresholds and
no recordable DPOAE (threshold arbitrarily set at 80 dB SPL; red diamond). (I)
entage of transduced IHCs (EGFP tagged).
and lower panels show and quantify (bar charts) the peroxisomes in untreated
rmalities are indicated by arrowheads). Error bars represent the SD in (A–I) and
includes a defective redox balance in the hair cells and neurons
of the auditory system.
In the context of noise exposure, the upregulation of Pjvk tran-
scription in the cochlea and the subsequent peroxisome prolifer-
ation in the hair cells and auditory neurons of wild-type mice
suggest that pejvakin-dependent peroxisome proliferation in
the auditory system is part of the physiological response to
high levels of acoustic energy that result in increased amounts
of ROS. This and the marked oxidative stress detected in the
Pjvk/ cochlea imply that the proliferation of peroxisomes plays
an antioxidant role, similar to that reported in other cell types
(Santos et al., 2005; Diano et al., 2011). The rapid elevation of
the hearing threshold in Pjvk/ mice in response to low-energy
sounds and the increase in interwave I-IV latency observed in
DFNB59 patients within a few seconds are consistent with an ac-
tivity-dependent H2O2 production that, due to impaired cellular
redox homeostasis, results in concentrations of H2O2 high
enough to impact on the activity of various target proteins
including ion channels and transporters (Rice, 2011). The wors-
ening of hearing sensitivity, 2 days later, in the mutant mice lack-
ing pejvakin, exacerbated by putting back the mice in a noisy
environment, fits the picture of the absence of sound-induced
biogenesis of peroxisomes (with their degeneration occurring
in a high acoustic energy environment). We thus conclude that
the hypervulnerability of Pjvk/ mice and DFNB59 patients to
sound does not result simply from an exacerbation, by sound,
of a pre-existing redox-balance defect, but is the consequence
of impaired adaptive proliferation of peroxisomes in the absence
of pejvakin. Both defective peroxisome proliferation in IHCs of
Pjvk/ mice in response to sound exposure and its partial re-
covery by pejvakin cDNA transfer support this conclusion. A
full recovery of the adaptive peroxisome proliferation produced
by sound exposure may require higher concentrations of pejva-
kin or the sound-induced modulation of Pjvk transcription (see
Figure 6A), which was missing in our rescue experiments (pejva-
kin cDNA expression being driven by a constitutive promoter).
In patients with hearing impairment, the amplification of sound
by hearing aids or direct electrical stimulation of the auditory
nerve by a cochlear implant delivers a stimulus with an energy
level similar to that shown here to worsen the hearing impairment
of Pjvk/ mice within 1 min of sound exposure. Therefore, in
cases of peroxisomal deficiency, as in DFNB59, specific protec-
tion against redox homeostasis failure is essential. Patients with
such conditions should avoid noisy environments and a benefi-
cial effect of hearing devices should require an antioxidant
protection. N-acetyl cysteine was the only antioxidant drug
tested here to display some, albeit limited, efficacy. By contrast,
AAV-mediated gene therapy could potentially provide full pro-
tection. Finally, deciphering the sound-stress-induced protec-
tive signaling pathway involving pejvakin might lead to the
discovery of therapeutic agents for NIHL.EXPERIMENTAL PROCEDURES
Audiological Studies in Mice
Auditory tests were performed in an anechoic room, on anesthetized animals
whose core temperatures were maintained at 37C (see the Supplemental
Experimental Procedures).Audiological Tests in Patients
Informed consent was obtained from all the subjects included in the study.
Pure-tone audiometry was performed with air- and bone-transmitted tones.
Hearing impairment was assessed objectively, by measuring ABRs and
transient-evoked otoacoustic emissions (TEOAEs). The nonlinear TEOAE
recording procedure was used (derived from the ILO88 system), making it
possible to extract TEOAEs from linear reflection artifacts from the middle
ear, and to evaluate background noise. TEOAE responses were analyzed in
1-kHz-wide bands centered on 1, 2, 3 and 4 kHz.
Generation of an Anti-pejvakin Monoclonal Antibody
The 30 end of the coding sequence of the Pjvk cDNA (NCBI:NM_001080711.2)
was inserted into a pGST-parallel-2 vector (derived from pGEX-4T-1; Amer-
sham). The resultant construct, encoding the C-terminal region of pejvakin
(residues 290–352; RefSeq:NP_001074180.1) fused to an N-terminal gluta-
thione S-transferase tag, was introduced into Escherichia coli BL21-Gold
(DE3)-competent cells (Stratagene). The pejvakin protein fragment was puri-
fied on a glutathione-Sepharose 4B column, then subjected to size-exclusion
chromatography and used as the antigen for immunization. Antibodies were
produced by immunizing Pjvk/mice. An immunoglobulin Gmonoclonal anti-
body (KD of 6 3 10
8 M), Pjvk-G21, was selected by ELISA on immunogen-
coated plates.
Statistical Analyses
Quantitative data are presented as mean ± SD, unless otherwise mentioned.
Statistical analyses were performed using GraphPad. Data were analyzed by
paired or unpaired Student’s t tests and, for multiple comparisons, either by
one-way or two-way ANOVA or by t tests with the Bonferroni correction. Sta-
tistical significance of the differences observed between groups is defined as
p < 0.05.
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